Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond

Positive

AI Analysis

Summary

Aurora Cannabis announced an accretive acquisition of Safari Flower Company, which received EU-GMP certification in July and is expected to contribute incremental revenue and EBITDA in fiscal Q2 2027.

Financial Highlights

Guidance

FY27 Q2 expected to show sequential growth in quarterly net revenue and adjusted EBITDA

Outcome Details

Safari Flower Company acquisition expected to contribute incremental revenue and adjusted EBITDA following EU-GMP certification received in July

Importance:5/10

Sentiment:

0.60

acquisitionEU-GMP certificationinternational expansioncannabis

Related Companies

$ACB

Read the original article

Published by PR Newswire Pharma on September 16, 2026 11:05 AM

Read Original